查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1803105

全球抗衰老贴片市场：2032 年预测 - 按类型、释放机制、贴片技术、分销管道、应用和地区进行分析

Senolytic Drug Patches Market Forecasts to 2032 - Global Analysis By Type, Release Mechanism, Patch Technology, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球抗衰老贴片市场预计在 2025 年达到 3.704 亿美元，到 2032 年将达到 6.472 亿美元，预测期内的复合年增长率为 8.3%。

抗衰老药物贴片是经皮给药系统，旨在透过选择性靶向和清除体内衰老细胞来施用抗衰老药物。老化细胞会导致老化和退化性症状，清除老化细胞可以改善组织功能。这些贴片能够透过皮肤控制、持续释放药物，为口服或註射给药提供了一种非侵入性替代方案。透过将药物创新与贴片技术相结合，抗衰老贴片代表了一种干预与老龄化相关的疾病的新方法。

根据临床试验的更新，抗衰老贴片正在获得发展势头，多项 II 期研究显示在治疗与老龄化相关的疾病方面有良好的效果。

加强抗衰老疗法的研究

扩大抗衰老疗法研究是抗衰老贴片市场的核心驱动力。受长寿解决方案和与老龄化相关的疾病管理需求日益增长的推动，生物製药公司正在增加对抗老化药物的投资。学术机构和私人企业正在进行大规模的临床前试验和临床试验，以检验抗衰老化合物。研发热潮正在提升产品可信度，并加速其获得监管部门批准的进程。因此，不断增长的科学证据不断增强市场认可度，使研究成为产业成长的基石。

研发成本高

高昂的研发成本是老年抗发炎药物市场发展的一大限制因素。药物研发、临床试验和监管核准都需要大量的资本支出，而中小企业往往难以负担。此外，经皮给药的复杂配方要求进一步增加了成本。这些财务负担会延迟产品的商业化，并限制新竞争对手的进入。虽然投资正在扩大，但持续的资金筹措仍然至关重要。因此，高昂的前期投资是扩大市场渗透的重大障碍。

与生物製药公司的合作

与生技和製药公司建立合作关係，为抗衰老贴片市场带来了重大机会。策略联盟使企业能够共用专业知识、先进平台和全球销售管道。随着抗衰老解决方案的认知度不断提升，合资企业加速了临床检验和监管核准。伙伴关係还能降低成本并提高扩充性，使药物贴片更具商业性可行性。随着跨产业合作的深化，协同创新预计将推动抗衰老贴片的广泛应用。

药品专利纠纷

药物製剂的专利纠纷对抗老化贴片市场构成重大威胁。随着多家公司研究类似的化合物和经皮技术，智慧财产权纠纷日益增加。此类纠纷会延迟产品上市，增加诉讼成本，并削弱投资人信心。中小企业尤其容易受到现有企业的专利挑战。此类纠纷会为商业化时程带来不确定性，并限制企业顺利进入市场。解决智慧财产权纠纷对于确保竞争稳定和促进持续创新仍然至关重要。

COVID-19的影响：

新冠疫情对抗老化贴片市场产生了双重影响。最初，医疗体系的中断延后了临床试验和研究活动。然而，这场危机也凸显了针对老龄化相关脆弱性进行弹性治疗方法的重要性。这种新的焦点加速了对抗老化和针对老化药物的投资。对远端患者监护和预防性医疗保健解决方案的需求进一步激发了市场兴趣。疫情过后，该行业获得了更充足的资金筹措，认知度也得到了提升，从而推动了抗衰老贴片的长期应用。

预计天然抗衰老化合物市场在预测期内将占据最大份额

随着消费者对植物来源和低毒治疗方案的偏好日益增长，天然抗衰老化合物领域预计将在预测期内占据最大的市场占有率。槲皮素和非瑟酮等天然衍生化合物因其安全性和生物活性而日益受到欢迎。越来越多的研究正在检验其在抑制细胞老化方面的有效性，这增强了市场的可信度。注重健康的消费者日益增长的认可度以及有利的法规环境，进一步巩固了其主导地位。

预测期内按需细分市场预计将以最高复合年增长率成长

预计在预测期内，按需治疗领域将实现最高成长率，这得益于对灵活个人化治疗方案日益增长的需求。患者越来越青睐可按需使用的贴剂，这与预防性护理和标靶治疗模式相符。这种模式减少了对持续用药的依赖，并提高了患者依从性。智慧药物传输技术的进步也加速了该领域的应用。因此，按需抗衰老贴片已成为该市场的潜在驱动力。

占比最大的地区：

预计亚太地区将在预测期内占据最大市场占有率，这得益于老年人口增长、生物技术研究投入增加以及政府支持的医疗保健计划等因素。中国、日本和韩国等国家在抗衰老和再生医学技术创新方面处于领先地位。此外，临床试验活动的活性化和跨国合作也推动了相关技术的采用率。医疗支出的不断增长和人口结构的快速变化，使得亚太地区在抗衰老贴片市场中的主导地位得以巩固。

复合年增长率最高的地区：

预计北美将在预测期内实现最高的复合年增长率，这得益于先进的研发基础设施、强劲的生物技术投资以及新疗法的早期应用。美国凭藉其强大的生物技术公司生态系统、临床研究机构和支持性法规结构，处于领先地位。消费者对抗老化干预措施的认识不断提高，正在刺激需求。此外，新兴企业与成熟製药公司之间的合作正在加强商业化进程。

免费客製化服务

此报告的订阅者可以从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 市场机会
  • 威胁
  • 技术分析
  • 应用分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 企业之间的竞争

5. 全球抗衰老贴片市场（按类型）

  • 天然抗老化合物
  • 合成抗衰老剂
  • 复方抗衰老製剂
  • 其他类型

6. 全球抗老贴片市场（依释放机制）

  • 控释
  • 延长释放
  • 脉动释放
  • 按需发布

7. 全球抗老贴片市场（按贴片技术）

  • 经皮储药贴剂
  • 矩阵补丁
  • 微针贴片
  • 奈米粒子增强贴片
  • 其他修补技术

8. 全球抗老贴片市场（依通路）

  • 医院药房
  • 零售药局
  • 网路药局
  • 直接供应合约

9. 全球抗衰老贴片市场（按应用）

  • 瘤
  • 神经退化性疾病
  • 心血管疾病
  • 肌肉骨骼疾病
  • 皮肤科/抗衰老
  • 代谢紊乱
  • 其他用途

第十章全球抗老贴片市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购（M&A）
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Unity Biotechnology
  • Calico Life Sciences
  • AgeX Therapeutics
  • Senolytic Therapeutics
  • Oisin Biotechnologies
  • Insilico Medicine
  • Recursion Pharmaceuticals
  • TA Sciences
  • Alkahest, Inc.
  • CohBar, Inc.
  • Human Longevity, Inc.
  • Juvenescence
  • BioAge Labs
  • Sierra Sciences
  • Cleara Biotech
Product Code: SMRC30630

According to Stratistics MRC, the Global Senolytic Drug Patches Market is accounted for $370.4 million in 2025 and is expected to reach $647.2 million by 2032 growing at a CAGR of 8.3% during the forecast period. Senolytic Drug Patches are transdermal delivery systems designed to administer senolytic agents that selectively target and eliminate senescent cells in the body. Senescent cells contribute to aging and degenerative conditions, and their removal can improve tissue function. These patches enable controlled, sustained release of drugs through the skin, offering a non-invasive alternative to oral or injectable routes. By combining pharmaceutical innovation with patch-based technology, senolytic drug patches represent a novel approach in age-related disease intervention.

According to clinical trial updates, senolytic drug patches are gaining momentum, with multiple Phase II studies showing promising results for age-related disease management.

Market Dynamics:

Driver:

Growing research on anti-aging therapies

Growing research on anti-aging therapies is a central driver of the senolytic drug patches market. Fueled by rising demand for longevity solutions and age-related disease management, biopharma companies are intensifying investments in senescence-targeting drugs. Academic institutions and private firms are conducting extensive preclinical and clinical studies to validate senolytic compounds. This surge in R&D enhances product credibility and accelerates regulatory pathways. Consequently, expanding scientific evidence continues to strengthen market acceptance, making research a cornerstone of industry growth.

Restraint:

High R&D development expenses

High R&D development expenses serve as a major restraint in the senolytic drug patches market. Drug discovery, clinical trials, and regulatory approvals demand significant capital, often stretching beyond the financial reach of smaller firms. Additionally, complex formulation requirements for transdermal delivery increase costs further. These financial burdens delay commercialization and limit entry of new competitors. While investment is growing, sustained funding remains critical. Thus, high upfront expenditures remain a substantial barrier to broader market penetration.

Opportunity:

Collaborations with biotech pharma firms

Collaborations with biotech and pharmaceutical companies represent a strong opportunity for the senolytic drug patches market. Strategic alliances allow firms to leverage shared expertise, advanced platforms, and global distribution channels. Spurred by increasing recognition of anti-aging solutions, joint ventures help accelerate clinical validation and regulatory approvals. Partnerships also reduce cost burdens and enhance scalability, making drug patches more commercially viable. As cross-industry collaboration grows, synergistic innovation is expected to catalyze broader adoption of senolytic patches.

Threat:

Patent disputes in drug formulations

Patent disputes in drug formulations pose a significant threat to the senolytic drug patches market. With multiple companies exploring similar compounds and transdermal technologies, intellectual property conflicts are rising. Such disputes delay product launches, inflate litigation costs, and weaken investor confidence. Smaller firms are particularly vulnerable to patent challenges from established players. These conflicts create uncertainty in commercialization timelines, restricting smooth market progression. Resolving IP battles remains essential for ensuring competitive stability and fostering sustained innovation.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the senolytic drug patches market. Initially, clinical trials and research activities were delayed due to disruptions in healthcare systems. However, the crisis also emphasized the importance of resilient therapies for age-related vulnerabilities. This renewed focus accelerated investment in anti-aging and senescence-targeted drugs. Remote patient monitoring and demand for preventive health solutions further boosted market interest. Post-pandemic, the sector witnessed stronger funding and heightened awareness, supporting long-term adoption of senolytic patches.

The natural senolytic compounds segment is expected to be the largest during the forecast period

The natural senolytic compounds segment is expected to account for the largest market share during the forecast period, propelled by rising consumer preference for plant-based and less toxic therapeutic solutions. Naturally derived compounds such as quercetin and fisetin are gaining traction for their safety profiles and bioactivity. Growing research validating their effectiveness in reducing cellular senescence enhances market trust. Increasing acceptance among health-conscious consumers and supportive regulatory environments further reinforce dominance.

The on-demand segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the on-demand segment is predicted to witness the highest growth rate, influenced by the rising need for flexible, personalized therapeutic delivery. Patients increasingly prefer patches that can be applied as needed, aligning with preventive care and targeted treatment models. This model reduces dependence on continuous dosage and improves adherence. Advances in smart drug delivery are also accelerating adoption. Consequently, on-demand senolytic drug patches are emerging as a high-potential growth driver in this market.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by expanding geriatric populations, rising investments in biotech research, and supportive government healthcare initiatives. Countries like China, Japan, and South Korea are spearheading innovation in anti-aging and regenerative medicine. Moreover, growing clinical trial activities and cross-border collaborations enhance adoption rates. With increasing healthcare spending and rapid demographic shifts, Asia Pacific solidifies its leadership position in the senolytic drug patches market.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by advanced R&D infrastructure, strong biotech investments, and early adoption of novel therapeutics. The U.S. leads with a robust ecosystem of biotech firms, clinical research institutions, and supportive regulatory frameworks. Rising awareness of anti-aging interventions among consumers accelerates demand. Furthermore, collaborations between startups and established pharmaceutical players strengthen commercialization.

Key players in the market

Some of the key players in Senolytic Drug Patches Market include Unity Biotechnology, Calico Life Sciences, AgeX Therapeutics, Senolytic Therapeutics, Oisin Biotechnologies, Insilico Medicine, Recursion Pharmaceuticals, T.A. Sciences, Alkahest, Inc., CohBar, Inc., Human Longevity, Inc., Juvenescence, BioAge Labs, Sierra Sciences and Cleara Biotech.

Key Developments:

In August 2025, Unity Biotechnology announced successful preclinical data on its senolytic drug patch targeting age-related osteoarthritis. The company emphasized localized delivery through patches as a safer, non-invasive alternative for long-term geroscience therapies.

In July 2025, Calico Life Sciences collaborated with a leading pharmaceutical partner to advance senolytic patch formulations. The initiative aims to combine AI-driven biology platforms with targeted delivery systems for age-related cellular clearance therapies.

In June 2025, AgeX Therapeutics unveiled progress on combining senolytic patches with regenerative stem cell therapies. This dual-approach solution is designed to tackle cellular aging, offering enhanced tissue repair and rejuvenation for elderly patients.

Types Covered:

  • Natural Senolytic Compounds
  • Synthetic Senolytic Agents
  • Combination Senolytic Formulations
  • Other Types

Release Mechanisms Covered:

  • Controlled Release
  • Extended Release
  • Pulsatile Release
  • On-Demand Release

Patch Technologies Covered:

  • Transdermal Reservoir Patches
  • Matrix Patches
  • Microneedle Patches
  • Nanoparticle-Enhanced Patches
  • Other Patch Technologies

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Direct Supply Agreements

Applications Covered:

  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular Diseases
  • Musculoskeletal Disorders
  • Dermatology & Anti-Aging
  • Metabolic Disorders
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Senolytic Drug Patches Market, By Type

  • 5.1 Introduction
  • 5.2 Natural Senolytic Compounds
  • 5.3 Synthetic Senolytic Agents
  • 5.4 Combination Senolytic Formulations
  • 5.5 Other Types

6 Global Senolytic Drug Patches Market, By Release Mechanism

  • 6.1 Introduction
  • 6.2 Controlled Release
  • 6.3 Extended Release
  • 6.4 Pulsatile Release
  • 6.5 On-Demand Release

7 Global Senolytic Drug Patches Market, By Patch Technology

  • 7.1 Introduction
  • 7.2 Transdermal Reservoir Patches
  • 7.3 Matrix Patches
  • 7.4 Microneedle Patches
  • 7.5 Nanoparticle-Enhanced Patches
  • 7.6 Other Patch Technologies

8 Global Senolytic Drug Patches Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hospital Pharmacies
  • 8.3 Retail Pharmacies
  • 8.4 Online Pharmacies
  • 8.5 Direct Supply Agreements

9 Global Senolytic Drug Patches Market, By Application

  • 9.1 Introduction
  • 9.2 Oncology
  • 9.3 Neurodegenerative Disorders
  • 9.4 Cardiovascular Diseases
  • 9.5 Musculoskeletal Disorders
  • 9.6 Dermatology & Anti-Aging
  • 9.7 Metabolic Disorders
  • 9.8 Other Applications

10 Global Senolytic Drug Patches Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Unity Biotechnology
  • 12.2 Calico Life Sciences
  • 12.3 AgeX Therapeutics
  • 12.4 Senolytic Therapeutics
  • 12.5 Oisin Biotechnologies
  • 12.6 Insilico Medicine
  • 12.7 Recursion Pharmaceuticals
  • 12.8 T.A. Sciences
  • 12.9 Alkahest, Inc.
  • 12.10 CohBar, Inc.
  • 12.11 Human Longevity, Inc.
  • 12.12 Juvenescence
  • 12.13 BioAge Labs
  • 12.14 Sierra Sciences
  • 12.15 Cleara Biotech

List of Tables

  • Table 1 Global Senolytic Drug Patches Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Senolytic Drug Patches Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Senolytic Drug Patches Market Outlook, By Natural Senolytic Compounds (2024-2032) ($MN)
  • Table 4 Global Senolytic Drug Patches Market Outlook, By Synthetic Senolytic Agents (2024-2032) ($MN)
  • Table 5 Global Senolytic Drug Patches Market Outlook, By Combination Senolytic Formulations (2024-2032) ($MN)
  • Table 6 Global Senolytic Drug Patches Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 7 Global Senolytic Drug Patches Market Outlook, By Release Mechanism (2024-2032) ($MN)
  • Table 8 Global Senolytic Drug Patches Market Outlook, By Controlled Release (2024-2032) ($MN)
  • Table 9 Global Senolytic Drug Patches Market Outlook, By Extended Release (2024-2032) ($MN)
  • Table 10 Global Senolytic Drug Patches Market Outlook, By Pulsatile Release (2024-2032) ($MN)
  • Table 11 Global Senolytic Drug Patches Market Outlook, By On-Demand Release (2024-2032) ($MN)
  • Table 12 Global Senolytic Drug Patches Market Outlook, By Patch Technology (2024-2032) ($MN)
  • Table 13 Global Senolytic Drug Patches Market Outlook, By Transdermal Reservoir Patches (2024-2032) ($MN)
  • Table 14 Global Senolytic Drug Patches Market Outlook, By Matrix Patches (2024-2032) ($MN)
  • Table 15 Global Senolytic Drug Patches Market Outlook, By Microneedle Patches (2024-2032) ($MN)
  • Table 16 Global Senolytic Drug Patches Market Outlook, By Nanoparticle-Enhanced Patches (2024-2032) ($MN)
  • Table 17 Global Senolytic Drug Patches Market Outlook, By Other Patch Technologies (2024-2032) ($MN)
  • Table 18 Global Senolytic Drug Patches Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 19 Global Senolytic Drug Patches Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 20 Global Senolytic Drug Patches Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 21 Global Senolytic Drug Patches Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 22 Global Senolytic Drug Patches Market Outlook, By Direct Supply Agreements (2024-2032) ($MN)
  • Table 23 Global Senolytic Drug Patches Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 Global Senolytic Drug Patches Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 25 Global Senolytic Drug Patches Market Outlook, By Neurodegenerative Disorders (2024-2032) ($MN)
  • Table 26 Global Senolytic Drug Patches Market Outlook, By Cardiovascular Diseases (2024-2032) ($MN)
  • Table 27 Global Senolytic Drug Patches Market Outlook, By Musculoskeletal Disorders (2024-2032) ($MN)
  • Table 28 Global Senolytic Drug Patches Market Outlook, By Dermatology & Anti-Aging (2024-2032) ($MN)
  • Table 29 Global Senolytic Drug Patches Market Outlook, By Metabolic Disorders (2024-2032) ($MN)
  • Table 30 Global Senolytic Drug Patches Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.